Home
Invest
Explore
About
Pricing

Search

Sign In
4DX
Asset Logo

4Dmedical Limited

🇦🇺 ASX

🩺 HEALTH CARE

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-8.33%
Annual Growth

4 years average annual growth

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

23
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

4DMedical Ltd. is a software technology company, which commercializes four-dimensional lung imaging platform called XV Technology. The company is headquartered in Melbourne, Victoria. The company went IPO on 2020-08-07. Through its flagship patented XV Technology, the Company enables physicians to understand regional airflow in the lungs and identify respiratory deficiencies earlier and with greater sensitivity as they breathe. This technology powers its FDA-cleared XV Lung Ventilation Analysis Software (XV LVA), which is a modality to dynamically quantify ventilation throughout the lungs, and its Computed Tomography-enabled counterpart software, CT LVAS. XV LVAS and CT LVAS reports are prepared using the Company’s software as a service (SaaS) delivery model using existing hospital imaging equipment or the Company's XV Scanner. The company initiated the commercial rollout of XV LVAS with I-MED Radiology Network (I-MED), which is a diagnostic imaging provider with approximately 250 clinics nationwide. The firm provides its lung imaging technology to other selected clinics across the I-MED network.

📈 Performance

Price History

-36.30%

1M

1Y

All Time

Graph

Table

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$0.47

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in 4DX

23

📊 Total Capital Earnings

$9K

🔃 Average investment frequency

35 weeks

💵 Average investment amount

$2,017

Last time a customer invested in 4DX

59 days
4DX investor breakdown
💵 Income of investors

More than 200k

11%

150k - 200k

100k - 150k

32%

50k - 100k

39%

Less than 50k

14%
👶 Age of investors

18 - 25

9%

26 - 34

35%

35 - 90

57%
🙋 Legal gender of investors

Female

26%

Male

74%

Pearlers who invest in 4DX also invest in...

Vanguard Australian Shares Index ETF

VAS

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

🙌 Performance (5Yr p.a)

3.66%

📊 Share price

$103.19 AUD

🇦🇺 AUSTRALIA

⛳️ DIVERSIFIED

🧱 MATERIALS

💸 FINANCIALS

Find Out More

VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.

🙌 Performance (5Yr p.a)

14.24%

📊 Share price

$140.55 AUD

⛳️ DIVERSIFIED

📈 HIGH PRICE GROWTH

🌏 GLOBAL

🤖 TECHNOLOGY

IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.

🙌 Performance (5Yr p.a)

20.94%

📊 Share price

$63.52 AUD

📈 HIGH PRICE GROWTH

🇺🇸 UNITED STATES

Pilbara Minerals Ltd. engages in the exploration and evaluation of mineral properties. The company is headquartered in Perth, Western Australia and currently employs 917 full-time employees. The company went IPO on 2007-09-19. The firm is primarily engaged in the exploration, development, and mining of minerals in Australia. Its 100% owned Pilgangoora hard-rock lithium operation is located approximately 120 kilometers (kms) from Port Hedland in Western Australia’s resource-rich Pilbara region. The operation consists of two processing plants: the Pilgan Plant, located on the northern side of the Pilgangoora area and produces spodumene and tantalite concentrates, and the Ngungaju Plant is located to the south produces spodumene concentrate. The company owns 70% of the Mt Francisco project, which is located 50 km south-west of the Pilgangoora Project and hosts the large occurrence of outcropping pegmatites located nearby to Port Hedland. The company is also pursuing a proposed downstream joint venture (JV) for the development of an approximately 43,000 tons per annum (tpa) lithium carbonate equivalent (LCE) lithium chemical conversion facility in South Korea.

🙌 Performance (5Yr p.a)

159.70%

📊 Share price

$2.26 AUD

⛏️ MINING

CSL

CSL

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. The company is headquartered in Melbourne, Victoria and currently employs 30,398 full-time employees. The Company’s areas of focus include rare and serious diseases, influenza vaccines and iron deficiency and nephrology. The Company’s segments include CSL Behring, CSL Seqirus and CSL Vifor. The CSL Behring segment manufactures, markets and distributes plasma products, gene therapies and recombinants. The CSL Seqirus segment manufactures, markets and distributes predominantly influenza related products and provides pandemic services to governments. The CSL Vifor segment manufactures, markets and distributes products in the therapeutic areas of iron deficiency and nephrology. Its CSL Plasma operates plasma collection networks, with more than 325 plasma collection centers in the United States, Europe and China. The firm operates in Australia, the United States, Germany, the United Kingdom, Switzerland and China. Its products include Respreeza, Zemaira, HAEGARDA, KCENTRA, Hepatitis B, Evogam and others.

🙌 Performance (5Yr p.a)

-0.53%

📊 Share price

$277.55 AUD

🧬 BIOTECHNOLOGY

🕊️ SOCIALLY AWARE

Want more shares? Try these...

📊 Share price

$0.05 AUD

5E Advanced Materials, Inc. is an exploration stage company, which engages in the provision of boron and lithium properties in Australia and the United States. The company is headquartered in Hesperia, California and currently employs 57 full-time employees. The company went IPO on 2022-03-01. The firm is a supplier of boron specialty and advanced materials, complemented by lithium co-product production. The company focuses on being a supplier of these critical materials to industries addressing global decarbonization, food and domestic security. The company focuses on developing capabilities ranging from upstream extraction and product sales of boric acid, lithium carbonate and potentially other co-products, to downstream boron advanced material processing and development. The company holds 100% of the rights through ownership in the 5E Boron Americas (Fort Cady) Complex (the Project) located in southern California, through its wholly owned subsidiary, 5E Boron Americas, LLC. Its Project is underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The firm's subsidiaries include American Pacific Borates Pty Ltd., and 5E Boron Americas, LLC.

📊 Share price

$0.07 AUD

⛏️ MINING

3P Learning Ltd. engages in the development, sale, and marketing of online educational programs. The company is headquartered in North Sydney, New South Wales. The company went IPO on 2014-07-09. The company is engaged in the development, sales and marketing of educational software and ebooks to schools and to parents of school-aged students, delivered via a software-as-a-service subscription model. Its segments include Business-to-School (B2B) and Business-to-Consumer (B2C). Its solutions include Mathletics, Reading Eggs, Mathseeds, Writing Legends and Brightpath Progress. Mathletics is the comprehensive mathematics program that provides instant access to thousands of digital and physical activities for practice, fluency and critical thinking in one place. Mathseeds develops early numeracy skills with captivating activities covering number sense, addition, subtraction and multiplication. Reading Eggs makes learning essential reading and phonics skills easy and fun. The program uses a sequence of online reading lessons, activities and books that keep students engaged and on task.

🙌 Performance (5Yr p.a)

-1.39%

📊 Share price

$0.81 AUD

🛍️ CONSUMER

4DS Memory Ltd. operates as a semiconductor development company. The company is headquartered in Perth, Western Australia. The company went IPO on 2010-12-09. The firm is engaged in the development of a non-volatile memory technology, pioneering Interface Switching resistive random-access memory (ReRAM) for gigabyte storage in mobile and cloud. Interface Switching ReRAM, an area-based ReRAM technology positioned for Storage Class Memory in mobile devices and cloud data centers. The company owns a patented Internet protocol (IP) portfolio, comprising 34 United States patents granted, which has been developed in-house to create high-density storage class memory. The 4DS Interface Switching ReRAM meets the essential requirements for Storage Class Memory close to DRAM. The firm also collaborates with imec, a research and hub in nanoelectronics and digital technologies.

🙌 Performance (5Yr p.a)

8.21%

📊 Share price

$0.08 AUD

🤖 TECHNOLOGY

📈 HIGH PRICE GROWTH

Compare
Add to watchlist